VYANT BIO Trademark

Trademark Overview


On Wednesday, December 16, 2020, a trademark application was filed for VYANT BIO with the United States Patent and Trademark Office. The USPTO has given the VYANT BIO trademark a serial number of 90386443. The federal status of this trademark filing is REGISTERED as of Tuesday, January 25, 2022. This trademark is owned by StemoniX, Inc.. The VYANT BIO trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Cells for medical or clinical use; stem cells for medical purposes

Research and development services in the field of biological tissue and organoid, namely, miniature or simplified biological organs; research and development services in the field of healthy and diseased tissue and organoids for use in scientific and medical research and drug development; custom design and development of biochemical assays; medical, pharmacological, and biological assay services, namely, custom design and development of biochemical assays; custom design and development of medical, pharmacological, and biological assays for drug development, screening, testing and evaluation; technical research and consultation in the field of in vivo and in vitro pharmacology, efficacy, and safety studies and testing including in vivo Investigational New Drug (IND) investigations; technical research and consultation in the field of in vivo and in vitro pharmacology, efficacy, and safety studies and testing including in vivo Investigational New Drug (IND) investigations for drugs, nutra...
vyant bio

General Information


Serial Number90386443
Word MarkVYANT BIO
Filing DateWednesday, December 16, 2020
Status700 - REGISTERED
Status DateTuesday, January 25, 2022
Registration Number6630446
Registration DateTuesday, January 25, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 27, 2021

Trademark Statements


Disclaimer with Predetermined Text"BIO"
Goods and ServicesCells for medical or clinical use; stem cells for medical purposes
Goods and ServicesResearch and development services in the field of biological tissue and organoid, namely, miniature or simplified biological organs; research and development services in the field of healthy and diseased tissue and organoids for use in scientific and medical research and drug development; custom design and development of biochemical assays; medical, pharmacological, and biological assay services, namely, custom design and development of biochemical assays; custom design and development of medical, pharmacological, and biological assays for drug development, screening, testing and evaluation; technical research and consultation in the field of in vivo and in vitro pharmacology, efficacy, and safety studies and testing including in vivo Investigational New Drug (IND) investigations; technical research and consultation in the field of in vivo and in vitro pharmacology, efficacy, and safety studies and testing including in vivo Investigational New Drug (IND) investigations for drugs, nutraceuticals, vitamins, and natural products; computer modeling services, namely, analysis and modeling of tissue and organoid performance and characteristics in response to medical and scientific treatments and effects

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 25, 2021
Primary Code005
First Use Anywhere DateWednesday, October 27, 2021
First Use In Commerce DateWednesday, October 27, 2021

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, June 18, 2021
Primary Code042
First Use Anywhere DateWednesday, October 27, 2021
First Use In Commerce DateWednesday, October 27, 2021

Trademark Owner History


Party NameVYANT BIO, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCHERRY HILL, NJ 08002

Party NameVYANT BIO, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressCHERRY HILL, NJ 08002

Party NameStemoniX, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressEden Prairie, MN 55347

Party NameStemoniX, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressEden Prairie, MN 55347

Trademark Events


Event DateEvent Description
Tuesday, January 25, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, December 21, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Saturday, December 18, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, December 1, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, November 29, 2021STATEMENT OF USE PROCESSING COMPLETE
Wednesday, October 27, 2021USE AMENDMENT FILED
Wednesday, November 17, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 27, 2021TEAS STATEMENT OF USE RECEIVED
Tuesday, September 21, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 27, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 27, 2021PUBLISHED FOR OPPOSITION
Wednesday, July 7, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, June 19, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, June 18, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 17, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 17, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 16, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 16, 2021NON-FINAL ACTION E-MAILED
Wednesday, June 16, 2021NON-FINAL ACTION WRITTEN
Wednesday, June 9, 2021ASSIGNED TO EXAMINER
Thursday, February 25, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM